ADXS11-001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ADXS11-001, covering 2017-05-12 to 2023-03-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer [Phase 1, Phase 2]